Multiomics Model Predicts Psoriasis Treatment Response
A new multiomics-clinical model predicts which psoriasis patients will achieve a 75% reduction in disease severity, identifying HLA-Cw6 genotype and ...
Tag: PASI 75
Tildrakizumab Clears Skin in Most Indian Psoriasis Patients in Phase III Trial
A phase III single-arm trial found that 93.9 percent of Indian patients with moderate-to-severe plaque psoriasis achieved PASI 75 after ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!